Presentation Information
[28-14-am10S]Differences in Safety Signal Detection Between Osimertinib and First- and Second-Generation EGFR-TKIs: A Pharmacovigilance Study Using a Spontaneous Reporting System
○Tomoya Sugimoto1,2, Yoshihiro Noguchi1, Rikuto Masuda1, Yukio Toyama2, Mitsuru Saguchi1, Tomoaki Yoshimura1 (1. Gifu pharm univ, 2. Toyota Memorial Hospital)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.